Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | FNTA | P49354 | 5/20 | 0.49 |
| ▸ | FNTB | P49356 | 3/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6561506 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL25334527 | 0.86 | ALDH1A1 (0.65) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL2160057 | 0.86 | ALDH1A1 (0.65) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL6797007 | 0.86 | ALDH1A1 (0.65) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL3504611 | 0.86 | ALDH1A1 (0.65) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL14844960 | 0.82 | ALDH1A1 (0.79) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL8662149 | 0.82 | ALDH1A1 (0.79) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL8662151 | 0.82 | ALDH1A1 (0.79) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL29142859 | 0.81 | ALDH1A1 (0.76) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL14993567 | 0.79 | ALDH1A1 (0.73) | ALDH1A1ALOX15FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2822682-B1 | MICROCAPSULES AND USES THEREOF | FIRMENICH & CIE (CH) | 2017-04-26 | — | — | EP | claimed |
| US-9334464-B2 | Microcapsules and uses thereof | FIRMENICH SA (CH) | 2016-05-10 | — | — | US | claimed |
| EP-2822682-A1 | MICROCAPSULES AND USES THEREOF | Firmenich SA (CH) | 2015-01-14 | — | — | EP | claimed |
| US-20140323376-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2014-10-30 | — | — | US | claimed |
| CN-103958047-A | Microcapsules and their use | FIRMENICH & CIE | 2014-07-30 | — | — | CN | claimed |
| WO-2013079435-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2013-06-06 | — | — | WO | claimed |
| US-12264295-B2 | Encapsulated pro-perfume compounds | FIRMENICH SA (CH) | 2025-04-01 | — | — | US | disclosed |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2023-03-23 | — | — | US | disclosed |
| US-20230032098-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | FIRMENICH SA (CH) | 2023-02-02 | — | — | US | disclosed |
| CN-115175658-A | Perfume system for perfumed consumer products | 弗门尼舍有限公司 | 2022-10-11 | — | — | CN | disclosed |
| EP-3942009-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | Firmenich SA (CH) | 2022-01-26 | — | — | EP | disclosed |
| CN-113614214-A | Encapsulated pro-fragrance compounds | 弗门尼舍有限公司 | 2021-11-05 | — | — | CN | disclosed |
| WO-2020188079-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | FIRMENICH SA (CH) | 2020-09-24 | — | — | WO | disclosed |
| WO-2013079435-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2013-06-06 | — | — | WO | disclosed |
| EP-1082287-B1 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS | FIRMENICH & CIE (CH) | 2004-03-17 | — | — | EP | disclosed |
| US-6492323-B2 | CONTROLLED RELEASE UPON EXPOSURE TO LIGHT | FIRMENICH SA (CH) | 2002-12-10 | — | — | US | disclosed |
| US-20010014661-A1 | Slow release of fragrant compounds in perfumery using alpha-keto esters | FIRMENICH SA (CH) | 2001-08-16 | — | — | US | disclosed |
| US-6218355-B1 | FOR RELEASING FRAGRANT COMPOUND OR COMPOUNDS IN A CONTROLLED MANNER, MAINTAINING A DESIRED SMELL OVER A PROLONGED PERIOD OF TIME | FIRMENICH SA (CH) | 2001-04-17 | — | — | US | disclosed |
| EP-1082287-A2 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS | FIRMENICH SA (CH) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999060990-A2 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR α-KETO ESTERS | FIRMENICH S.A. (CH) | 1999-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014661-A1 | Slow release of fragrant compounds in perfumery using alpha-keto esters | FAAH, KHK, FAAH2 | ALDH1A1 122/4885ALOX15 265/4885FNTA 2287/4885 |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | PORCN, FAAH2, FASN | ALDH1A1 817/4885ALOX15 115/4885FNTA 2518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.